Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Recruiting now · Not applicable
Conditions studied: Breast Cancer
In brief
The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation. Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients. This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.
Key facts
- Study ID
- NCT05056350
- Run by
- Institut du Cancer de Montpellier - Val d'Aurelle
- People needed
- 25
- Starts
- 2021-09-13
- Expected to finish
- 2027-08-22
- Last updated by the study team
- 2025-02-12
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years
- Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy)
- Patient who has completed adjuvant treatment, except for hormonotherapy
- Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis
- Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field
- Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job
- Patient who signed the informed consent after informed information by her clinician
You may not qualify if…
- Metastatic breast cancer or any other cancer within the last 5 years
- Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy)
- Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study
- Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test)
- Physical inability to answer questionnaires
Where it is running
- Institut du Cancer de Montpellier — Montpellier, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.